anchor instance (Q119807)

From ScienceSource
Jump to: navigation, search
No description defined
edit
Language Label Description Also known as
English
anchor instance
No description defined

    Statements

    compensate for the reduction in GLP-1 associated with pasireotide [[19]]. Antidiabetic medication, primarily
    0 references
    , was administered in 38–48 % of patients in acromegaly trials [[13], [14], [26]]. Mean HbA1c levels
    0 references
    215
    0 references
    57
    0 references
    19,354
    0 references
    17 April 2019
    0 references
    0 references
    Hyperglycemia induced by pasireotide in patients with Cushing's disease or acromegaly (4996868)
    0 references
     
    edit
      edit
        edit
          edit
            edit
              edit